• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

No disease left behind.

作者信息

Arshad Muzamil, Lynch Connor, Katipally Rohan R, Pitroda Sean P, Weichselbaum Ralph R

出版信息

Oncotarget. 2025 Mar 13;16:163-166. doi: 10.18632/oncotarget.28700.

DOI:10.18632/oncotarget.28700
PMID:40079896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11906142/
Abstract
摘要

相似文献

1
No disease left behind.一个都不落下。
Oncotarget. 2025 Mar 13;16:163-166. doi: 10.18632/oncotarget.28700.
2
First report of pulmonary large cell neuroendocrine carcinoma treated with stereotactic body radiation therapy.立体定向体部放射治疗肺大细胞神经内分泌癌的首例报告。
Rep Pract Oncol Radiother. 2019 Nov-Dec;24(6):507-510. doi: 10.1016/j.rpor.2019.08.005. Epub 2019 Sep 2.
3
The optimal stereotactic body radiotherapy dose with immunotherapy for pulmonary oligometastases: a retrospective cohort study.免疫疗法联合立体定向体部放疗治疗肺寡转移瘤的最佳剂量：一项回顾性队列研究
J Thorac Dis. 2024 Oct 31;16(10):7072-7085. doi: 10.21037/jtd-24-1624. Epub 2024 Oct 25.
4
Exploring the Evolving Landscape of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma.探索肝细胞癌立体定向体部放射治疗的发展态势
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102386. doi: 10.1016/j.jceh.2024.102386. Epub 2024 Aug 3.
5
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium.转移灶定向立体定向放疗联合靶向治疗或免疫治疗：EORTC-ESTRO 寡转移治疗联盟的系统评价和共识建议。
Lancet Oncol. 2023 Mar;24(3):e121-e132. doi: 10.1016/S1470-2045(22)00752-5.
6
The role of immunotherapy in combination with oligometastasis-directed therapy: a narrative review.免疫疗法联合寡转移灶定向治疗的作用：叙述性综述。
Ann Palliat Med. 2021 May;10(5):6028-6044. doi: 10.21037/apm-20-1528. Epub 2021 Jan 4.
7
Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries.立体定向放疗与靶向治疗联合应用：德语国家的治疗模式调查。
Strahlenther Onkol. 2019 Mar;195(3):199-206. doi: 10.1007/s00066-018-01422-5. Epub 2019 Feb 8.
8
Use of Palliative Site-Directed Ablation in Pediatric Oncology: A Retrospective Study From the Pediatric Surgical Oncology Research Collaborative.姑息性局部消融在儿科肿瘤学中的应用：来自儿科外科肿瘤学研究协作组的一项回顾性研究
Pediatr Blood Cancer. 2025 Feb;72(2):e31453. doi: 10.1002/pbc.31453. Epub 2024 Nov 24.
9
Survival Is Worse in Patients Completing Immunotherapy Prior to SBRT/SRS Compared to Those Receiving It Concurrently or After.与同步接受免疫治疗或在立体定向体部放疗/立体定向放射外科治疗后接受免疫治疗的患者相比，在立体定向体部放疗/立体定向放射外科治疗之前完成免疫治疗的患者生存率更低。
Front Oncol. 2022 May 27;12:785350. doi: 10.3389/fonc.2022.785350. eCollection 2022.
10
Cost of cardiac stereotactic body radioablation therapy versus catheter ablation for treatment of ventricular tachycardia.心脏立体定向体部放射治疗与导管消融治疗室性心动过速的成本比较。
Pacing Clin Electrophysiol. 2022 Sep;45(9):1124-1131. doi: 10.1111/pace.14512. Epub 2022 Jun 9.

本文引用的文献

1
A phase III randomised trial on the addition of a contact X-ray brachytherapy boost to standard neoadjuvant chemo-radiotherapy for organ preservation in early rectal adenocarcinoma: 5 year results of the OPERA trial.一项关于在早期直肠腺癌器官保留的标准新辅助放化疗基础上加用接触性X线近距离放疗增强治疗的III期随机试验：OPERA试验的5年结果
Ann Oncol. 2025 Feb;36(2):208-215. doi: 10.1016/j.annonc.2024.10.827. Epub 2024 Nov 10.
2
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.立体定向体部放射治疗局限性前列腺癌的 3 期临床试验。
N Engl J Med. 2024 Oct 17;391(15):1413-1425. doi: 10.1056/NEJMoa2403365.
3
Stereotactic body radiation therapy (SBRT) in patients with hepatocellular cancer-a narrative review and expert opinion.
肝细胞癌患者的立体定向体部放射治疗——叙述性综述与专家意见
J Gastrointest Oncol. 2024 Aug 31;15(4):1880-1892. doi: 10.21037/jgo-23-771. Epub 2024 Feb 2.
4
Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease.分担负担：对于转移疾病负荷量低的患者，采用确定性局部治疗代替免疫检查点阻断的理由。
J Clin Oncol. 2024 Oct 10;42(29):3387-3391. doi: 10.1200/JCO.24.00549. Epub 2024 Jul 22.
5
Stereotactic Body Radiotherapy and Liver Transplant for Liver Cancer: A Nonrandomized Controlled Trial.立体定向体部放疗联合肝移植治疗肝癌：一项非随机对照试验。
JAMA Netw Open. 2024 Jun 3;7(6):e2415998. doi: 10.1001/jamanetworkopen.2024.15998.
6
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial.总新辅助治疗的直肠癌患者临床反应分级的器官保存和生存：OPRA 随机临床试验的二次分析。
JAMA Netw Open. 2024 Jan 2;7(1):e2350903. doi: 10.1001/jamanetworkopen.2023.50903.
7
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial.度伐利尤单抗联合放化疗对比安慰剂用于局部晚期宫颈癌（CALLA）的随机、双盲、III 期临床试验
Lancet Oncol. 2023 Dec;24(12):1334-1348. doi: 10.1016/S1470-2045(23)00479-5.
8
Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer.使用立体定向体部放射治疗低危或中危前列腺癌患者的 1 期剂量递增研究的长期结果。
Eur Urol Oncol. 2024 Aug;7(4):812-820. doi: 10.1016/j.euo.2023.10.019. Epub 2023 Nov 10.
9
Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study).SBRT 能否改善不可切除局部晚期胰腺癌的预后？142 例患者的长期临床结果、毒性和预后因素（STEP 研究）。
Curr Oncol. 2023 Jul 24;30(7):7073-7088. doi: 10.3390/curroncol30070513.
10
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.立体定向消融放疗联合或不联合免疫治疗早期或孤立性肺实质复发性淋巴结阴性非小细胞肺癌：一项开放标签、随机、2 期临床试验。
Lancet. 2023 Sep 9;402(10405):871-881. doi: 10.1016/S0140-6736(23)01384-3. Epub 2023 Jul 18.